Published in Respiration on December 15, 2005
Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth. Infect Immun (2012) 1.02
Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica. PLoS One (2011) 0.84
Induction of release and up-regulated gene expression of interleukin (IL)-8 in A549 cells by serine proteinases. BMC Cell Biol (2006) 0.81
Chronic obstructive pulmonary disease beyond cigarette smoke. Respiration (2005) 0.77
The impact of IFN-γ receptor on SLPI expression in active tuberculosis: association with disease severity. Am J Pathol (2014) 0.77
PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat Med (2004) 4.64
JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem (2005) 2.76
Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res (2009) 2.04
Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension (2002) 1.83
Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer. JOP (2010) 1.59
Insulin-induced GLUT4 translocation involves protein kinase C-lambda-mediated functional coupling between Rab4 and the motor protein kinesin. Mol Cell Biol (2003) 1.56
Myoclonus and metabolic alkalosis from licorice in antacid. Intern Med (2004) 1.53
Pneumonitis due to an herbal medicine, Otsu-ji-to. Eur J Intern Med (2010) 1.38
Downregulation of ENaC activity and expression by TNF-alpha in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.31
Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med (2009) 1.26
G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol Endocrinol (2005) 1.23
Serum levels of CA19-9 in patients with nonmalignant respiratory diseases. J Clin Lab Anal (2007) 1.22
Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol (2013) 1.20
Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features. Lung Cancer (2012) 1.17
Specific organ metastases and survival in small cell lung cancer. Oncol Lett (2012) 1.13
A patient with pulmonary lymphangitic carcinomatosis successfully treated with TS-1 and cisplatin. Intern Med (2007) 1.10
Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes. J Biol Chem (2003) 1.10
Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89. Am J Pathol (2003) 1.10
GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J (2004) 1.10
Prevalence of COPD. Respirology (2014) 1.08
Xenopus tropicalis: an ideal experimental animal in amphibia. Exp Anim (2010) 1.05
Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba. Int J Radiat Oncol Biol Phys (2010) 1.03
Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. Gastroenterology (2003) 1.02
Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2003) 1.02
Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences. Respirology (2008) 1.02
A case of primary lung cancer producing alpha-fetoprotein. Can Respir J (2004) 1.01
Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans. Arterioscler Thromb Vasc Biol (2003) 1.01
Targeted gene disruption in the Xenopus tropicalis genome using designed TALE nucleases. Zoolog Sci (2013) 1.01
A population-based study of gefitinib in patients with non-small cell lung cancer. Med Oncol (2008) 0.99
Proton beam therapy of Stage II and III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2010) 0.99
Liver metastasis at the time of initial diagnosis of lung cancer. Med Oncol (2003) 0.97
Life as an evacuee after the Fukushima Daiichi nuclear power plant accident is a cause of polycythemia: the Fukushima Health Management Survey. BMC Public Health (2014) 0.97
Postoperative follow-up for patients with non-small cell lung cancer. Onkologie (2010) 0.94
Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Exp Biol Med (Maywood) (2011) 0.93
Overexpression of CD-11b and CXCR1 on circulating neutrophils: its possible role in COPD. Chest (2007) 0.92
Muscle architectural characteristics in women aged 20-79 years. Med Sci Sports Exerc (2003) 0.91
A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT). Radiother Oncol (2008) 0.90
Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress. Arterioscler Thromb Vasc Biol (2003) 0.90
High-dose conformal radiotherapy for patients with stage III non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys (2010) 0.89
Phylogenetic Clades 6 and 8 of Enterohemorrhagic Escherichia coli O157:H7 With Particular stx Subtypes are More Frequently Found in Isolates From Hemolytic Uremic Syndrome Patients Than From Asymptomatic Carriers. Open Forum Infect Dis (2014) 0.89
Body mass index and lung cancer: a case-control study of subjects participating in a mass-screening program. Chest (2005) 0.89
Serum KL-6 levels in lung cancer patients with or without interstitial lung disease. J Clin Lab Anal (2010) 0.88
Effect of heavy-ion radiotherapy on pulmonary function in stage I non-small cell lung cancer patients. Chest (2002) 0.88
Occam's Razor or Hickam's dictum: a paraneoplastic or coincidental occurrence of lung cancer and Guillain-Barré syndrome. Intern Med (2014) 0.88
Portal vein tumor thrombus of liver metastasis from lung cancer. Acta Medica (Hradec Kralove) (2009) 0.87
Small intestinal metastasis from small cell lung cancer. Intern Med (2006) 0.87
ZBP-89 mediates butyrate regulation of gene expression. J Nutr (2003) 0.87
The regulation of amiloride-sensitive epithelial sodium channels by tumor necrosis factor-alpha in injured lungs and alveolar type II cells. Respir Physiol Neurobiol (2008) 0.87
Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy. Med Oncol (2014) 0.86
beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1. Mol Cell Biol (2004) 0.86
The basic data for residents aged 16 years or older who received a comprehensive health check examinations in 2011-2012 as a part of the Fukushima Health Management Survey after the great East Japan earthquake. Fukushima J Med Sci (2015) 0.86
Liraglutide enhances insulin sensitivity by activating AMP-activated protein kinase in male Wistar rats. Endocrinology (2014) 0.85
Plasma orexin-A levels and body composition in COPD. Chest (2003) 0.85
Modulation of Na+ transport and epithelial sodium channel expression by protein kinase C in rat alveolar epithelial cells. Can J Physiol Pharmacol (2005) 0.85
Metastasis to appendix from lung adenocarcinoma. Int J Gastrointest Cancer (2005) 0.85
Time from finding abnormality on mass-screening to final diagnosis of lung cancer. Oncol Rep (2003) 0.85
Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer. Oncol Lett (2012) 0.85
Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running statistical analysis. Anticancer Res (2010) 0.85
Speckle reduction mechanism in laser rear projection displays using a small moving diffuser. J Opt Soc Am A Opt Image Sci Vis (2010) 0.85
Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screening. Oncol Lett (2012) 0.85
Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes. Life Sci (2011) 0.84
Spontaneous pneumomediastinum after air travel. Am J Emerg Med (2008) 0.84
Co-morbid illnesses in patients with respiratory disease. Tuberk Toraks (2007) 0.84
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group. Med Oncol (2012) 0.84
Radiologic findings in primary pulmonary plasmacytoma. J Thorac Imaging (2005) 0.83
Brain metastasis as the first manifestation of lung cancer. Am J Med (2003) 0.83
Cytokeratin 19 fragment in patients with nonmalignant respiratory diseases. Chest (2003) 0.83
Pneumomediastinum in a patient with pneumocystis jirovecii pneumonia. Intern Med (2012) 0.83
Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis. J Clin Lab Anal (2005) 0.83
Outcome of patients with lung cancer detected incidentally. Oncol Rep (2004) 0.83
Management of spontaneous dissection of the superior mesenteric artery. Intern Med (2004) 0.82
Adenosine kinase-deficient mutant of Saccharomyces cerevisiae accumulates S-adenosylmethionine because of an enhanced methionine biosynthesis pathway. Appl Microbiol Biotechnol (2012) 0.82
Survival difference in NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy. Med Oncol (2013) 0.82
Epidermal growth factor receptor mutations: effect on volume doubling time of non-small-cell lung cancer patients. J Thorac Oncol (2014) 0.82
Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells. Int J Oncol (2004) 0.82
Application of conditional probability analysis to distant metastases from lung cancer. Oncol Lett (2011) 0.82
Patients with lung cancer with metachronous or synchronous gastric cancer. Clin Lung Cancer (2009) 0.81
Chemotherapy for Langerhans cell sarcoma. J Orthop Sci (2009) 0.81
How lifestyle affects health--changes in health status before and after the earthquake. Fukushima J Med Sci (2014) 0.81
IL-17F Induces CCL20 in Bronchial Epithelial Cells. J Allergy (Cairo) (2011) 0.81
Management of limy bile syndrome: no therapy, laparotomy or endoscopic treatment? Intern Med (2003) 0.80
Recovery from carcinomatous meningitis by erlotinib. Onkologie (2011) 0.80
Glutathione depletion promotes aluminum-mediated cell death of PC12 cells. Biol Pharm Bull (2005) 0.80
Pulmonary toxicity by an oral anti-neoplatic agent, S-1. Intern Med (2008) 0.80
Pleural small cell carcinoma. Lung Cancer (2006) 0.80
Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer. Eur J Cardiothorac Surg (2007) 0.80
Physical Performance Measures Associated With Locomotive Syndrome in Middle-Aged and Older Japanese Women. J Geriatr Phys Ther (2015) 0.79
Ultrasonographic diagnosis of colitis. Intern Med (2005) 0.79
Cardiac tamponade originating from gastric cancer. J Gastroenterol (2009) 0.79
Lung cancer among medical professionals. Chest (2002) 0.79
Complex effect of adenovirus early region proteins on innate immune system. Inflamm Allergy Drug Targets (2006) 0.79